Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients

被引：0
|
作者：
J. Riethmueller
M. Ballmann
T. W. Schroeter
P. Franke
R. von Butler
A. Claass
S. Junge
G. Doering
M. Stern
机构：
[1] University Children’s Hospital,Pediatric Dept.
[2] University Children’s Hospital Kiel,undefined
[3] University of Hannover,undefined
[4] Hygiene-Institut,undefined
[5] University of Tübingen,undefined
来源：
Infection | 2009年 / 37卷
关键词：
Ceftazidime; Tobramycin; Cystic Fibrosis Patient; Postantibiotic Effect; Multiple Daily Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：424 / 431
页数：7
相关论文
共 48 条
  • [1] Tobramycin Once- vs Thrice-Daily for Elective Intravenous Antipseudomonal Therapy in Pediatric Cystic Fibrosis Patients
    Riethmueller, J.
    Ballmann, M.
    Schroeter, T. W.
    Franke, P.
    von Butler, R.
    Claass, A.
    Junge, S.
    Doering, G.
    Stern, M.
    INFECTION, 2009, 37 (05) : 424 - 431
  • [2] Continuous vs Thrice-Daily Ceftazidime for Elective Intravenous Antipseudomonal Therapy in Cystic Fibrosis
    Riethmueller, J.
    Junge, S.
    Schroeter, T. W.
    Kuemmerer, K.
    Franke, P.
    Ballmann, M.
    Claass, A.
    Broemme, S.
    Jeschke, R.
    Hebestreit, A.
    Staab, D.
    Koetz, K.
    Doering, G.
    Stern, M.
    INFECTION, 2009, 37 (05) : 418 - 423
  • [3] Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis
    J. Riethmueller
    S. Junge
    T. W. Schroeter
    K. Kuemmerer
    P. Franke
    M. Ballmann
    A. Claass
    S. Broemme
    R. Jeschke
    A. Hebestreit
    D. Staab
    K. Koetz
    G. Doering
    M. Stern
    Infection, 2009, 37 : 418 - 423
  • [4] Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt, Olaf
    Lehmann, Christine
    Madabushi, Rajanikanth
    Kumar, Vipul
    Derendorf, Hartmut
    Welte, Tobias
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) : 822 - 829
  • [5] Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients
    Guglielmo, BJ
    Quan, LA
    Stulbarg, MS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 1040 - 1042
  • [6] Pharmacokinetics of comparison of once daily tobramycin or thrice daily dose in cystic fibrosis patients
    Canis, F
    Trivier, D
    Vic, P
    Ategbo, S
    Turck, D
    Husson, MO
    PATHOLOGIE BIOLOGIE, 1998, 46 (06): : 449 - 451
  • [7] Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation
    Sung, L
    Dupuis, LL
    Bliss, B
    Taddio, A
    Abdolell, M
    Allen, U
    Rolland, M
    Tong, A
    Taylor, T
    Doyle, J
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (24): : 1869 - 1877
  • [8] Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis
    Touw, D. J.
    Knox, A. J.
    Smyth, A.
    JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (05) : 327 - 333
  • [9] Pharmacokinetics of once and twice daily dosing of intravenous tobramycin in paediatric patients with cystic fibrosis
    Turner, R. Brigg
    Elbarbry, Fawzy
    Biondo, Lisa
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (04) : 304 - 307
  • [10] Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis
    Massie, John
    Cranswick, Noel
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2006, 42 (10) : 601 - 605
12345